Investor Presentaiton

Key Milestones targeted for future SUN PHARMA • Enhance share of specialty/branded business US Business • Continue to focus on complex generics and high entry barrier segments • Ensure broad product offering to customers across multiple dosage forms Gain critical mass in key therapeutic segments India Business ROW Business •Improve productivity of India business • Maintain leadership position in a fiercely competitive market . Continuously innovate to ensure high brand equity with doctors • Gain critical mass in key emerging markets • Enhance product basket in emerging markets • Improve profitability in developed European markets © Sun Pharmaceutical Industries Limited. All Rights Reserved. 52 42

View entire presentation